Diethylstilbestrol

Diethylstilbestrol structure

Diethylstilbestrol 3-D balls

Diethylstilbestrol (DES) is a synthetic, nonsteroidal estrogen that was previously used in medical treatments and as an additive in livestock and poultry feed. It has a complex history marked by therapeutic uses and later, significant health concerns.

History

Diethylstilbestrol was first synthesized in 1938. During the mid-20th century, DES was commonly prescribed for a variety of conditions in women, ranging from suppressing lactation to preventing miscarriages. Its use in animal feed aimed to promote growth and improve meat production.

Medical Uses

The primary medical application of DES was to prevent complications during pregnancy. It was believed that by supplementing estrogen, miscarriages, and premature deliveries could be minimized. However, subsequent research showed that DES was ineffective for this purpose.

Use in Livestock and Poultry

In agriculture, DES was used as a growth-promoting agent in livestock and poultry feed. The estrogenic properties of DES were believed to enhance meat production by accelerating weight gain and promoting the deposition of certain fats.

Health Concerns and Bans

By the early 1970s, it became evident that prenatal exposure to DES increased the risk of a rare form of vaginal cancer known as clear cell adenocarcinoma in daughters of the women who took DES. Further studies also revealed that DES was associated with increased risks of breast cancer, infertility, and other health issues in both the women who took it and their offspring.

Consequently, the FDA in the USA and its counterparts in many other countries banned the use of DES in pregnant women. The use of DES in animal feed was also phased out.

Current Status

The use of DES in both human medicine and animal agriculture has significantly diminished due to associated health risks. Today, DES serves mainly as a case study in pharmaceutical regulation and the importance of rigorous drug testing.

- Weight loss injections in NYC (generic and brand names):
- Zepbound / Mounjaro, Wegovy / Ozempic, Saxenda
Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.

NYC weight loss doctor appointments

Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.

Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC

Advertise on WikiMD

WikiMD's Wellness Encyclopedia

Let Food Be Thy Medicine
Medicine Thy Food - Hippocrates

Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.